Consequently, the combination of cetuximab, a blocking antibody to EGFR with radiotherapy was shown to significantly improve outcome of locally advanced SCCHN when compared to radiotherapy alone [8]. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.